Technical Description
This invention includes the Novel drug formulation for bone repair and regeneration, focusing on an effective ratio of bioactive glass particles and a direct thrombin inhibitor.
Problems Addressed
- Less Effective Bioactive Glass
- Non-Optimized Formulation
- Lower Thrombin Inhibition
Tech Features
- Direct Thrombin Inhibitor
- Optimal Formulation Ratio
- Barium-enriched Glass Formula
- Innovative Formulation
Target Audience
- Medical Devices Industry
- Pharmaceutical Industry
- Orthopaedic Implants Manufacturing
- Biomedical Materials Manufacturing
- Regenerative Medicine Sector
Tech ID: P27-1140 TRL 4 Patent Status: Granted Available For Exclusive and Non-exclusive License
